Proteomics and the haematologist

Clinical and Laboratory Haematology

Volumn 26, Issue 2, 2004, Pages 77-86

  Rees Unwin, K S ^a   Morgan, G J ^b   Davies, F E ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Cancer; Haematological malignancy; Mass spectrometry; Proteomics; Two dimensional separation

Indexed keywords

BIOCHEMICAL MARKER; CA 125 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; PROSTATE SPECIFIC ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ANALYTIC METHOD; B CELL LEUKEMIA; BURKITT LYMPHOMA; CHRONIC LYMPHATIC LEUKEMIA; DIAGNOSTIC TEST; ELECTROSPRAY MASS SPECTROMETRY; GENETIC VARIABILITY; HEMATOLOGIC MALIGNANCY; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PHENOTYPE; PRECANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN MICROARRAY; PROTEOMICS; REVIEW; SURFACE ENHANCED LASER DESORPTION IONIZATION; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

BLOTTING, WESTERN; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HEMATOLOGIC NEOPLASMS; HUMANS; MASS SPECTROMETRY; NEOPLASM PROTEINS; PHENOTYPE; PHYSICIANS; PROTEIN ARRAY ANALYSIS; PROTEOMICS; TUMOR MARKERS, BIOLOGICAL;

EID: 1942442170     PISSN: 01419854     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2257.2004.00598.x     Document Type: Review

References (27)

1. Anderson L. & Seilhamer J. (1997) A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 18, 533-537.
2. Caron M., Imam-Sghiouar N., Poirier F., Le Caer J.P., Labas V. & Joubert-Caron R. (2002) Proteomic map and database of lymphoblastoid proteins. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences 771, 197-209.
3. H genes. Molecular Cell Proteomics 2, 1331-1341.
4. Fenn J.B., Mann M., Meng C.K., Wong S.F. & Whitehouse C.M. (1989) Electrospray ionization for mass spectrometry of large biomolecules. Science 246, 64-71.
5. Grossi F., Spizzo R., Belvedere O., Cacitti V., Valent F., Rizzato S., Aita M., Fasola G., Morelli A. & Beltrami C.A. (2003) Molecular profiling of IIIA N2 non-small cell lung cancer (NSCLC) by tissue microarrays: focus on tumor-specific molecular targets for novel therapies. An Alpe-Adria Thoracic Oncology Multidisciplinary group study (ATOM 014). Journal of Clinical Oncology 22, 63S Abstract 2555.
6. Hanash S.M., Neel J.V., Baier L.J., Rosenblum B.B., Niezgoda W. & Markel D. (1986) Genetic analysis of thirty-three platelet polypeptides detected in two-dimensional polyacrylamide gels. American Journal of Human Genetics 38, 352-360.
7. Hanash S.M., Madoz-Gurpide J. & Misek D.E. (2002) Identification of novel targets for cancer therapy using expression proteomics. Leukemia 16, 478-485.
8. Joubert-Caron R., Le Caer J.P., Montandon F., Poirier F., Pontet M., Imam N., Feuillard J., Bladier D., Rossier J. & Caron M. (2000) Protein analysis by mass spectrometry and sequence database searching: a proteomic approach to identify human lymphoblastoid cell line proteins. Electrophoresis 21, 2566-2575.
9. Karas M. & Hillenkamp F. (1988) Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. Annals of Chemistry 60, 2299-2301.
10. Klose J. & Kobalz U. (1995) Two-dimensional electrophoresis of proteins: an updated protocol and implications for a functional analysis of the genome. Electrophoresis 16, 1034-1059.
11. Komarova E.A., Diatchenko L., Rokhlin O.W., Hill J.E., Wang Z.J., Krivokrysenko V.I., Feinstein E. & Gudkov A.V. (1998) Stress-induced secretion of growth inhibitors: a novel tumor suppressor function of p53. Oncogene 17, 1089-1096.
12. Liotta L.A., Ferrari M. & Petricoin E. (2003) Clinical Proteomics. Nature 425, 905.
13. Ng P.W., Porter A.G. & Janicke R.U. (1999) Molecular cloning and characterization of two novel pro-apoptotic isoforms of caspase-10. Journal of Biological Chemistry 274, 10301-10308.
14. O'Farrell P.H. (1975) High resolution two-dimensional electrophoresis of proteins. Journal of Biological Chemistry 250, 4007-4021.
15. Pantuck A.J., Seligson D., Huang Y., Horvath S., Bui M., Zisman A., Han K., Janzen N., Figlin R. & Belldegrun A. (2003) EpCAM is an independent predictor of survival in renal cell carcinoma. Journal of Clinical Oncology 22, 399 Abstract 1602.
16. Poirier F., Pontet M., Labas V., Le Caer J.P., Sghiouar-Imam N., Raphael M., Caron M. & Joubert-Caron R. (2001) Two-dimensional database of a Burkitt lymphoma cell line (DG 75) proteins: protein pattern changes following treatment with 5′-azycytidine. Electrophoresis 22, 1867-1877.
17. Polyak K., Xia Y., Zweier J.L., Kinzler K.W. & Vogelstein B. (1997) A model for p53-induced apoptosis. Nature 389, 300-305.
18. Shipp M.A., Ross K.N., Tamayo P., Weng A.P., Kutok J.L., Aguiar R.C., Gaasenbeek M., Angelo M., Reich M., Pinkus G.S., Ray T.S., Koyal M.A., Last K.W., Norton A., Lister T.A., Mesirov J., Neuberg D.A., Kander E.S., Aster J.C. & Golub T.R. (2002). Diffuse large B-cell lymphoma outcome prediction by gene expression profiling and supervised machine learning. Nature Medicine 8, 68-74.
19. Silzel J.W., Cercek B., Dodson C., Tsay T. & Obremski R.J. (1998) Mass-sensing, multianalyte microarray immunoassay with imaging detection. Clinical Chemistry 44, 2036-2043.
20. Strahler J.R., Kuick R., Eckerskorn C., Lottspeich F., Richardson B.C., Fox D.A., Stoolman L.M., Hanson C.A., Nichols D., Tueche H.J. et al. (1990) Identification of two related markers for common acute lymphoblastic leukemia as heat shock proteins. Journal of Clinical Investigation 85, 200-207.
21. Tager M., Kroning H., Thiel U. & Ansorge S. (1997) Membrane-bound proteindisulfide isomerase (PDI) is involved in regulation of surface expression of thiols and drug sensitivity of B-CLL cells. Experimental Hematology 25, 601-607.
22. Tzankov A., Zimpfer A., Lugli A., Krugmann, J., Went P., Schraml P., Maurer R., Ascani S., Pileri S., Geley S. & Dimhofer S. (2003) High-throughput tissue microarray analysis of G1-cyclin alterations in classical Hodgkin's lymphoma indicates overexpression of cyclin E1. Journal of Pathology 199, 201-207
23. Vlahou A., Schellhammer P.F., Mendrinos S., Patel K., Kondylis F.I., Gong L., Nasim S. & Wright J.G., Jr (2001) Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine. American Journal of Pathology 158, 1491-1502.
24. Voss T., Ahorn H., Haberl P., Dohner H. & Wilgenbus K. (2001) Correlation of clinical data with proteomics profiles in 24 patients with B-cell chronic lymphocytic leukemia. International Journal of Cancer 91, 180-186.
25. Wasinger V.C., Cordwell S.J., Cerpa-Poljak A., Yan J.X., Gooley A.A., Wilkins M.R., Duncan M.W., Harris R., Williams K.L. & Humphery-Smith I. (1995) Progress with gene-product mapping of the mollicutes: Mycoplasma genitalium. Electrophoresis 16, 1090-1094.
26. Wright G.L., Cazares L.H., Leung S.-M., Nasim S., Adam B.-L., Yip T.T., Schelljhammer P.F., Gong L. & Vlahou A. (1999) ProteinChip surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures. Prostate Cancer and Prostatic Diseases 2, 264-276.
27. Zhang P., Liu B., Kang S.W., Seo M.S., Rhee S.G. & Obeid L.M. (1997) Thioredoxin peroxidase is a novel inhibitor of apoptosis with a mechanism distinct from that of Bcl-2. Journal of Biological Chemistry 272, 30615-30618.